BioCentury
ARTICLE | Strategy

Worldwide web

How Hanmi is using a network of experts to build a pipeline with global reach

February 8, 2016 8:00 AM UTC

Korean biotech Hanmi Pharmaceutical Co. Ltd. is on a mission to globalize. And with six out-licensing deals announced last year, the company appears to be reaping the rewards of its investment in both new technology platforms and a worldwide network intended to provide expertise and global reach.

Hanmi was founded in 1973 as a developer of generic drugs. Today it sells new salts, dosage forms and fixed-dose combinations of generic drugs in China and Korea itself, and worldwide via partnerships. The company reported a net profit of W43 billion ($35 million) in 2014...